FormFactor (FORM) Q3 2026 Earnings Call Transcript

FormFactor reported record Q3 revenue of $280.5 million, up 38.4% year over year, with non-GAAP EPS of $1.04 and gross margin of 56.5%; management said Q4 guidance puts full-year 2026 revenue above $1 billion for the first time. TRITON revenue is now expected to exceed $30 million in 2026, up from an initial $10 million–$20 million estimate, while Teradyne made a $300 million investment tied to an expanded partnership. Management expects Farmers Branch to reach about $400 million in annual probe-card revenue capacity exiting 2027, though current capacity constraints and facility ramp inefficiencies remain risks; the roughly 53% gross-margin baseline excludes nonrecurring tariff refunds and favorable component costs.

Analysis

The key underwriting question is no longer demand but conversion: FormFactor says capacity is binding, so the next leg depends on qualifying and ramping Farmers Branch without sacrificing yields or customer quality. The stated $400M is exit-rate capability, not 2027 revenue; investors risk capitalizing it too early. The first production shipment ahead of schedule is useful evidence, but not proof of a smooth volume ramp.

Headline margins overstate run-rate economics: tariff refunds and favorable component costs flatter Q3, while management’s ~53% baseline is the better anchor. A Q4 margin near guidance would support the cost-improvement thesis; sustained margin deterioration as start-up costs move into cost of revenue would challenge it. The separate $300M Teradyne investment may validate the ecosystem opportunity, but without the investment terms it should not be treated as equivalent to recurring customer demand or earnings.

Second-order upside reaches TSMC and the wider AI supply chain if probe-card capacity unlocks GPU/custom-ASIC production test; that is supplier enablement, not evidence of a direct change in TSMC economics. Conversely, tighter capacity could defer FormFactor shipments and leave customers or competing probe-card providers with opportunities. Photonics adds optionality, but current scale is too small to underwrite the core thesis. Over 1–3 months, watch Q4 delivery, qualification cadence, and margin normalization; over 6–18 months, execution and utilization at the new facility dominate. Consensus may be extrapolating peak reported margins and treating capacity as revenue, while underweighting the possibility that the capacity bottleneck prolongs growth if demand persists.

Key Decisions for Investors

• FORM: Favor a measured long, preferably on post-earnings volatility rather than chasing the print. The thesis is capacity-constrained demand plus structural yield/efficiency gains, not Q3’s 56.5% margin. Reassess if Q4 revenue misses the guided range or baseline gross margin falls materially below ~53% without a clearly temporary cause.
• Set an alert for Farmers Branch milestones through 2027: customer qualifications, production volume, yields, and whether ramp costs are offset as planned. Treat the $400M figure as annualized capacity, not booked revenue; reduce exposure if ramp timing slips or quality issues emerge.
• TER: Do not infer a material earnings catalyst from the $300M investment alone. Verify the transaction’s instrument, ownership/economic terms, and any commercial commitments before assigning value; strategic alignment can benefit both firms without guaranteeing incremental Teradyne sales.
• Monitor TSMC and GPU/custom-ASIC supply-chain signals as a read-through, not a standalone TSM trade: FormFactor’s shipments may enable test capacity, but the transcript does not establish a material change to TSMC’s economics.